SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Profit Before Tax | ₹-387 Cr | ₹-223 Cr |
Adjustment | ₹-11 Cr | ₹6.99 Cr |
Changes In working Capital | ₹-27 Cr | ₹141 Cr |
Cash Flow after changes in Working Capital | ₹-425 Cr | ₹-74 Cr |
Cash Flow from Operating Activities | ₹-429 Cr | ₹-69 Cr |
Cash Flow from Investing Activities | ₹392 Cr | ₹-548 Cr |
Cash Flow from Financing Activities | ₹42 Cr | ₹617 Cr |
Net Cash Inflow / Outflow | ₹4.74 Cr | ₹-0.64 Cr |
Opening Cash & Cash Equivalents | ₹0.58 Cr | ₹1.22 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
Effect of Foreign Exchange Fluctuations | ₹0.00 Cr | - |
Closing Cash & Cash Equivalent | ₹5.33 Cr | ₹0.58 Cr |
Compare Cashflow Statement of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,729.6 Cr | -1.5% | 29.4% | -60.4% | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹29,204.1 Cr | 0.7% | 11.2% | 2.4% | Stock Analytics | |
SAGILITY INDIA | ₹20,059.5 Cr | 2.3% | -0.4% | NA | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹7,711.7 Cr | 3.7% | -2.5% | -26.9% | Stock Analytics | |
JUST DIAL | ₹6,940.3 Cr | -1.8% | -3.4% | 1.2% | Stock Analytics | |
AWFIS SPACE SOLUTIONS | ₹4,815.6 Cr | 6.8% | 4.1% | NA | Stock Analytics |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -1.5% |
29.4% |
-60.4% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses